Chomard P, Seguin C, Loireau A, Autissier N, Artur Y
Unité de Biochimie Pharmacologique, UFR des Sciences Pharmaceutiques et Biologiques, Dijon, France.
Biochem Pharmacol. 1998 May 15;55(10):1591-601. doi: 10.1016/s0006-2952(97)00675-8.
We studied the effect of different thyroid compounds [(I2, monoiodo-L-tyrosine (MIT), diiodo-L-tyrosine (DIT), L-thyronine (T0), 3,5-diiodo-L-thyronine (T2), 3,5,3'-triiodo-L-thyronine (T3), 3,3',5'-triiodo-L-thyronine (rT3), 3,5,3',5'-tetraiodo-L-thyronine (T4), 3,5-diiodothyroacetic acid (TA2), 3,5,3'-triiodothyroacetic acid (TA3) and 3,5,3',5'-tetraiodothyroacetic acid (TA4)] or thyromimetics [(3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) and 3,5-diiodo-3'-isopropyl-thyroacetic acid (IpTA2)] on in vitro copper-induced oxidation of low-density lipoproteins (LDL). Human native LDL (0.05 g protein/L) oxidation was induced by 2.5 micromol/L of CuCl2. Conjugated dienes were measured spectrophotometrically for up to 10 hr. The length of the lag phase (Tlag), maximum velocity of the reaction (Vmax) and the maximum amount of generated dienes were obtained from kinetic data. T3 increased Tlag and decreased Vmax with a dependence upon concentration (0 to 3 micromol/L). There was no difference between the Dmax obtained with Cu2+ alone or in the presence of the various compounds (1 micromol/L). I2, MIT and DIT did not modify any parameter of the oxidation kinetic. T0 and T2 had the same antioxidant efficiency as T3, whereas T4 only decreased Vmax. rT3 increased Tlag less than did T3, whereas DIMIT was the thyronine that had the most important effect. TA2 and TA, were the most efficient antioxidant compounds. TA4 decreased Tlag less than TA3 did, whereas IpTA2 had an effect weaker than that of the physiological acetic derivatives. The data suggest that thyroid hormones and derivatives have LDL-antioxidant properties, their importance being related to their 4'-hydroxy diphenyl ether structure and depending upon the nature and the position of substituents in this structure.
我们研究了不同甲状腺化合物[(碘(I2)、一碘-L-酪氨酸(MIT)、二碘-L-酪氨酸(DIT)、L-甲状腺素(T0)、3,5-二碘-L-甲状腺素(T2)、3,5,3'-三碘-L-甲状腺原氨酸(T3)、3,3',5'-三碘-L-甲状腺原氨酸(反T3,rT3)、3,5,3',5'-四碘-L-甲状腺原氨酸(T4)、3,5-二碘甲状腺乙酸(TA2)、3,5,3'-三碘甲状腺乙酸(TA3)和3,5,3',5'-四碘甲状腺乙酸(TA4)]或甲状腺激素类似物[(3,5-二甲基-3'-异丙基-L-甲状腺原氨酸(DIMIT)和3,5-二碘-3'-异丙基-甲状腺乙酸(IpTA2)]对体外铜诱导的低密度脂蛋白(LDL)氧化的影响。用2.5微摩尔/升的氯化铜诱导人天然LDL(0.05克蛋白质/升)氧化。用分光光度法测定共轭二烯长达10小时。从动力学数据中获得滞后期(Tlag)的长度、反应的最大速度(Vmax)和生成的二烯的最大量。T3增加了Tlag并降低了Vmax,且呈浓度依赖性(0至3微摩尔/升)。单独使用Cu2+或在各种化合物(1微摩尔/升)存在下获得的Dmax之间没有差异。I2、MIT和DIT没有改变氧化动力学的任何参数。T0和T2具有与T3相同的抗氧化效率,而T4仅降低了Vmax。反T3增加Tlag的程度小于T3,而DIMIT是具有最重要作用的甲状腺原氨酸。TA2和TA3是最有效的抗氧化化合物。TA4降低Tlag的程度小于TA3,而IpTA2的作用比生理性乙酸衍生物弱。数据表明甲状腺激素及其衍生物具有LDL抗氧化特性,其重要性与其4'-羟基二苯醚结构有关,并取决于该结构中取代基的性质和位置。